Track the NewAmsterdam Pharma Co N.V. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). The latest transaction was filed on 22 July 2026 (Levée d'options). Among the most active insiders: Kooij Louise Frederika. All data is free.
90
Insider Decl.
n/a
Thresholds
€763,264
12 ops.
Buy Volume
€21m
24 ops.
Sell Volume
41Σ signal
Buys €763,264€21m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
NewAmsterdam Pharma Co N.V. is a biopharmaceutical company focused on developing innovative treatments for metabolic diseases. It is listed on NASDAQ under the ticker NAMS.